Beta-glucan contamination of pharmaceutical products: How much should we accept? Claire BartonKim VigorJames F. Spicer Review Open access 29 July 2016 Pages: 1289 - 1301
The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice Claudia LanternaAndrea MusumeciVincenzo Russo Original Article 12 August 2016 Pages: 1303 - 1315
Quantification of PD-L1 and PD-1 expression on tumor and immune cells in non-small cell lung cancer (NSCLC) using non-enzymatic tissue dissociation and flow cytometry Amanda CharginRian MorganBruce K. Patterson Original Article 26 August 2016 Pages: 1317 - 1323
NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells John O. RichardsAlex J. AlbersJudy A. Tjoe Original Article 29 August 2016 Pages: 1325 - 1335
Erratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells John O. RichardsAlex J. AlbersJudy A. Tjoe Erratum 01 October 2016 Pages: 1337 - 1337
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma Robert A. FenstermakerMichael J. CiesielskiAlan D. Hutson Original Article Open access 30 August 2016 Pages: 1339 - 1352
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas Megan C. DugganCaroline JochemsWilliam E. Carson III Original Article 31 August 2016 Pages: 1353 - 1364
The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression Aline Van AckerEls LouagieGeorges Leclercq Original Article 01 September 2016 Pages: 1365 - 1375
Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes Andreas GlogerDanilo RitzDario Neri Original Article 06 September 2016 Pages: 1377 - 1393
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial Paolo A. AsciertoVito VanellaNicola Mozzillo Original Article 07 September 2016 Pages: 1395 - 1400
Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma Kentaro MikiYorihisa OritaYasuharu Sato Original Article 10 September 2016 Pages: 1401 - 1410
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma Irina V. TiperTonya J. Webb Original Article 10 September 2016 Pages: 1411 - 1421
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015 Michele MaioErica BertocciNIBIT Meeting Report 12 September 2016 Pages: 1423 - 1431
